Having been in this stock since 1994, during the RIGS and ACT days, and Lindsey Rosenwald days, I have witnessed some heroes and crooks along the way. The only CEO who delivered finish line accomplishments was David Bupp. He generated $10 million in annual probe sales, which helped fund the development of Lymphoseek, a gold standard in its field, but poorly managed as a company asset. The most damage was done due to MG's stupid stunts and mismanagement, liquidation of the probe revenue, abandonment of RIGS technology, and overall a general dislike for loyal long term shareholders. I also believe his junior, JL started off with a 1/20 reverse stock split which was an arrow to the heart of the Longs, proving JL just as evil as MG, JMO. I consider both of them dishonest so I do not trust them.
John K Scott may be our savior, or he may have a more devious plot; we shall see in the next couple years. Will the company get bought out? I think so, either that or it will go private. After all, the company assets really amount to a file folder/usb drive of research data and Intellectual Property. Jubilent could buy it with lunch money. So, what's next? You tell me.